Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
10.1016/j.jcmgh.2020.12.009
Saved in:
Main Authors: | Huang, Daniel Q, Muthiah, Mark D, Zhou, Lei, Jumat, Halisah, Tan, Wan Xin, Lee, Guan Huei, Lim, Seng Gee, Kow, Alfred, Bonney, Glenn, Shridhar, Iyer, Lim, Yi Ting, Wee, Aileen, Pang, Yin Huei, Soon, Gwyneth, Chow, Pierce, Dan, Yock Young |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Language: | English |
Published: |
ELSEVIER INC
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/207536 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
by: Chew, V., et al.
Published: (2014) -
Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: An update
by: Ou, K., et al.
Published: (2014) -
Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
by: Zhao Y., et al.
Published: (2019) -
Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
by: Chong, Yong Chun, et al.
Published: (2020) -
Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma
by: Nissom, P.M., et al.
Published: (2014)